Join the EURION virtual Annual meeting for an update on the latest advances in EURION’s research to improve the identification of endocrine disruptors and joint activities within the cluster. The morning (9:00-12:15) of the first day will be open for all scientists and stakeholders who want to learn more about the advances of the EURION cluster and its projects in developing new testing and screening methods for identifying endocrine disruptors. The rest of the programme will be open for EURION members only to discuss joint activities and project results, and thereby facilitate cross-project collaboration and maximise synergies.
EURION, the European Cluster to Improve Identification of Endocrine Disruptors (EDs), consists of eight H2020 research projects focusing on the development of new ED test methods targeting relevant endpoints that are not sufficiently covered by current regulatory tests (https://eurion-cluster.eu/).
Program open to stakeholders and others
EURION members only meeting
5 EURION Working Groups will held a meeting in parallel sessions
For each topics, discussion points have been identified to kick-start cross-project collaboration/discussions (e.g. readout for adverse effects, pre-validation/validation status of candidate assays,....)
The discussions will be based on topics of common interest to enable cross-project collaboration
These projects have received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825161 (ATHENA), No. 825762 (EDCMET), No. 825759 (ENDPOINTs), No. 825753 (ERGO), No. 825100 (FREIA), No. 825489 (GOLIATH), No. 825745 (SCREENED), No. 825712 (OBERON). This output reflects only the author’s view and the European Union cannot be held responsible for any use that may be made of the information contained therein.